|
|
|
MISMATCH REPAIR PATHWAY (PW:0000662)
DescriptionDNA
mismatch repair (MMR) represents a highly conserved pathway that assures the correct
base matching of the duplex. Despite the high replication fidelity of
polymerases, mismatched bases may be introduced into the daughter strand during
DNA replication; small deletion/insertion loops may be introduced during replication
of repetitive DNA tracts. If uncorrected, mismatches will give rise to potentially
deleterious mutations. MMR pathway has been well studied and characterized in E. coli. In eukaryotes, the best characterized
system is S. cerevisiae; human
components have been identified and assayed in cell extracts and reconstituted
systems. E. coli MMR is initiated by
recognition of mismatched bases by MutS; MutL relays MutS activity to downstream
events. Msh proteins are the mammalian counterparts of MutS; Mlh and Pms
proteins are the counterparts of MutL. Base excision is mediated by Exo1; protection
of ssDNA and prevention of hairpin formation is provided by Rpa - a trimeric
single-stranded DNA-binding protein complex. Repair of the single-stranded gap
involves re-synthesis and ligation carried out by DNA polymerase delta and DNA
ligase 1. Several polymerases maintain the integrity of the genome by carrying
out DNA replication, recombination and repair. Delta and epsilon polymerases are
involved in DNA replication and in DNA base and strand repair pathways; only delta
appears to be specifically involved in MMR. Base excision and nucleotide
excision are base repair pathways that fix DNA damaged by exogenous or
endogenous agents. Polymerase delta requires a moving platform; this is
provided by the processivity factor Pcna (known as the clamp) and a pentameric
protein complex Rfc (Replication factor C) that loads it (known as the
clamp-loader). Rfc binds the ring shaped Pcna in the presence of ATP; ATP-bound
Rfc binds DNA and this event prompts ATP hydrolysis and ejection of the Rfc
complex. The now closed Pcna clamp on DNA is in the proper orientation for use
by the polymerase. Delta polymerase and Rcf appear to bind/compete for the same
site on the Pcna clamp. Interactions between components of MMR and between some
of these components and other proteins have been established; the significance
of many remains elusive. And so are many of the molecular details of the
pathway such as strand specificity and recognition or Rpa clearance amongst
them. Alterations in MMR pathway have been implicated in colorectal and other
forms of cancer. To see the ontology report for annotations, GViewer and
download, click here
[click to see the ontology
report for associated GO term - GO:0006298 and KEGG map - map03430]...(less)
|
Pathway Diagram:
|
|
|
Genes in Pathway:
mismatch repair pathway
|
| G |
Exo1 |
exonuclease 1 |
|
|
ISS |
13 |
91,619,024 |
91,644,366 |
RGD:2306716 |
RGD |
| G |
Exo1 |
exonuclease 1 |
|
|
IEA |
13 |
91,619,024 |
91,644,366 |
RGD:6907045 |
KEGG |
| G |
Hmgb1 |
high mobility group box 1 |
|
|
ISS |
|
|
|
RGD:2306716 |
RGD |
| G |
Lig1 |
ligase I, DNA, ATP-dependent |
|
|
ISS |
1 |
73,728,892 |
73,767,429 |
RGD:2306716 |
RGD |
| G |
Lig1 |
ligase I, DNA, ATP-dependent |
|
|
IEA |
1 |
73,728,892 |
73,767,429 |
RGD:6907045 |
KEGG |
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
|
ISS |
8 |
115,616,396 |
115,653,471 |
RGD:2306716 |
RGD |
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
|
IEA |
8 |
115,616,396 |
115,653,471 |
RGD:6907045 |
KEGG |
| G |
Mlh3 |
mutL homolog 3 (E. coli) |
|
|
ISS |
6 |
109,280,910 |
109,318,893 |
RGD:2306716 |
RGD |
| G |
Mlh3 |
mutL homolog 3 (E. coli) |
|
|
IEA |
6 |
109,280,910 |
109,318,893 |
RGD:6907045 |
KEGG |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
ISS |
6 |
11,199,906 |
11,258,350 |
RGD:2306716 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
IEA |
6 |
11,199,906 |
11,258,350 |
RGD:6907045 |
KEGG |
| G |
Msh3 |
mutS homolog 3 (E. coli) |
|
|
ISS |
2 |
22,462,934 |
22,606,874 |
RGD:2306716 |
RGD |
| G |
Msh3 |
mutS homolog 3 (E. coli) |
|
|
IEA |
2 |
22,462,934 |
22,606,874 |
RGD:6907045 |
KEGG |
| G |
Pcna |
proliferating cell nuclear antigen |
|
|
ISS |
3 |
120,008,715 |
120,012,589 |
RGD:2306716 |
RGD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
|
IEA |
3 |
120,008,715 |
120,012,589 |
RGD:6907045 |
KEGG |
| G |
Pms1 |
postmeiotic segregation increased 1 (S. cerevisiae) |
|
|
ISS |
9 |
45,203,344 |
45,292,624 |
RGD:2306716 |
RGD |
| G |
Pms2 |
postmeiotic segregation increased 2 (S. cerevisiae) |
|
|
ISS |
12 |
11,004,507 |
11,028,754 |
RGD:2306716 |
RGD |
| G |
Pms2 |
postmeiotic segregation increased 2 (S. cerevisiae) |
|
|
IEA |
12 |
11,004,507 |
11,028,754 |
RGD:6907045 |
KEGG |
| G |
Pold1 |
polymerase (DNA directed), delta 1, catalytic subunit |
|
|
ISS |
1 |
95,010,719 |
95,021,686 |
RGD:2306716 |
RGD |
| G |
Pold1 |
polymerase (DNA directed), delta 1, catalytic subunit |
|
|
IEA |
1 |
95,010,719 |
95,021,686 |
RGD:6907045 |
KEGG |
| G |
Pold2 |
polymerase (DNA directed), delta 2, accessory subunit |
|
|
ISS |
14 |
86,535,757 |
86,541,920 |
RGD:2306716 |
RGD |
| G |
Pold2 |
polymerase (DNA directed), delta 2, accessory subunit |
|
|
IEA |
14 |
86,535,757 |
86,541,920 |
RGD:6907045 |
KEGG |
| G |
Pold3 |
polymerase (DNA-directed), delta 3, accessory subunit |
|
|
ISS |
1 |
157,453,059 |
157,490,563 |
RGD:2306716 |
RGD |
| G |
Pold3 |
polymerase (DNA-directed), delta 3, accessory subunit |
|
|
IEA |
1 |
157,453,059 |
157,490,563 |
RGD:6907045 |
KEGG |
| G |
Pold4 |
polymerase (DNA-directed), delta 4, accessory subunit |
|
|
ISS |
1 |
206,815,462 |
206,817,131 |
RGD:2306716 |
RGD |
| G |
Pold4 |
polymerase (DNA-directed), delta 4, accessory subunit |
|
|
IEA |
1 |
206,815,462 |
206,817,131 |
RGD:6907045 |
KEGG |
| G |
Rfc1 |
replication factor C (activator 1) 1 |
|
|
ISS |
14 |
45,665,717 |
45,741,391 |
RGD:2306716 |
RGD |
| G |
Rfc1 |
replication factor C (activator 1) 1 |
|
|
IEA |
14 |
45,665,717 |
45,741,391 |
RGD:6907045 |
KEGG |
| G |
Rfc2 |
replication factor C (activator 1) 2 |
|
|
ISS |
12 |
23,185,550 |
23,198,655 |
RGD:2306716 |
RGD |
| G |
Rfc2 |
replication factor C (activator 1) 2 |
|
|
IEA |
12 |
23,185,550 |
23,198,655 |
RGD:6907045 |
KEGG |
| G |
Rfc3 |
replication factor C (activator 1) 3 |
|
|
ISS |
12 |
3,224,493 |
3,235,256 |
RGD:2306716 |
RGD |
| G |
Rfc3 |
replication factor C (activator 1) 3 |
|
|
IEA |
12 |
3,224,493 |
3,235,256 |
RGD:6907045 |
KEGG |
| G |
Rfc4 |
replication factor C (activator 1) 4 |
|
|
ISS |
11 |
79,935,273 |
79,950,589 |
RGD:2306716 |
RGD |
| G |
Rfc4 |
replication factor C (activator 1) 4 |
|
|
IEA |
11 |
79,935,273 |
79,950,589 |
RGD:6907045 |
KEGG |
| G |
Rfc5 |
replication factor C (activator 1) 5 |
|
|
ISS |
12 |
40,395,942 |
40,405,498 |
RGD:2306716 |
RGD |
| G |
Rfc5 |
replication factor C (activator 1) 5 |
|
|
IEA |
12 |
40,395,942 |
40,405,498 |
RGD:6907045 |
KEGG |
| G |
Rpa1 |
replication protein A1 |
|
|
ISS |
10 |
62,613,169 |
62,656,565 |
RGD:2306716 |
RGD |
| G |
Rpa1 |
replication protein A1 |
|
|
IEA |
10 |
62,613,169 |
62,656,565 |
RGD:6907045 |
KEGG |
| G |
Rpa2 |
replication protein A2 |
|
|
ISS |
5 |
152,369,550 |
152,380,370 |
RGD:2306716 |
RGD |
| G |
Rpa2 |
replication protein A2 |
|
|
IEA |
5 |
152,369,550 |
152,380,370 |
RGD:6907045 |
KEGG |
| G |
Rpa3 |
replication protein A3 |
|
|
ISS |
4 |
33,304,334 |
33,307,365 |
RGD:2306716 |
RGD |
| G |
Rpa3 |
replication protein A3 |
|
|
IEA |
4 |
33,304,334 |
33,307,365 |
RGD:6907045 |
KEGG |
| G |
Ssbp1 |
single-stranded DNA binding protein 1, mitochondrial |
|
|
IEA |
4 |
68,027,304 |
68,036,581 |
RGD:6907045 |
KEGG |
altered mismatch repair pathway
|
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
|
ISS |
8 |
115,616,396 |
115,653,471 |
RGD:4143515 |
RGD |
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
|
ISS |
8 |
115,616,396 |
115,653,471 |
RGD:2306714 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
ISS |
6 |
11,199,906 |
11,258,350 |
RGD:2306714 |
RGD |
| G |
Pms1 |
postmeiotic segregation increased 1 (S. cerevisiae) |
|
|
ISS |
9 |
45,203,344 |
45,292,624 |
RGD:2306714 |
RGD |
| G |
Pms2 |
postmeiotic segregation increased 2 (S. cerevisiae) |
|
|
ISS |
12 |
11,004,507 |
11,028,754 |
RGD:2306714 |
RGD |
|
|
|
Pathway Gene Annotations |
|
Disease Annotations Associated with Genes in the mismatch repair pathway
|
|
|
|
|
|
| Lig1 | Immunologic Deficiency Syndromes , Metabolism, Inborn Errors | | Mlh1 | Breast Neoplasms , Carcinoma, Renal Cell , Cervical Intraepithelial Neoplasia , Colorectal Neoplasms , Colorectal Neoplasms, Hereditary Nonpolyposis , Endometrial Neoplasms , Hydatidiform Mole , Lynch Syndrome II , Muir-Torre Syndrome , Neoplasms, Germ Cell and Embryonal , Neoplasms, Multiple Primary , Turcot syndrome , Urinary Bladder Neoplasms , Uterine Cervical Neoplasms , Vulvar Neoplasms | | Mlh3 | Colorectal Neoplasms , Colorectal Neoplasms, Hereditary Nonpolyposis , Endometrial Neoplasms | | Msh2 | Breast Neoplasms , Carcinoma, Renal Cell , Cervical Intraepithelial Neoplasia , Colorectal Neoplasms , Colorectal Neoplasms, Hereditary Nonpolyposis , Endometrial Neoplasms , Hydatidiform Mole , Hydatidiform Mole, Invasive , Lynch syndrome I (site-specific colonic cancer) , Muir-Torre Syndrome , Neoplasm Metastasis , Neoplasms, Germ Cell and Embryonal , Ovarian Neoplasms , Prostatic Neoplasms , Seizures , Turcot syndrome , Urinary Bladder Neoplasms , Urogenital Neoplasms , Uterine Cervical Neoplasms , Vulvar Neoplasms | | Msh3 | Colorectal Neoplasms , Digestive System Neoplasms , Endometrial Neoplasms | | Pcna | Brain Ischemia , Breast Neoplasms , Carcinoma, Ductal, Breast , Carcinoma, Renal Cell , Leiomyoma , Neoplasm Metastasis , Neoplasms, Germ Cell and Embryonal , Phyllodes Tumor , Seminoma , Testicular Neoplasms , Wilms Tumor | | Pms1 | Carcinoma, Pancreatic Ductal , Colorectal Neoplasms , Colorectal Neoplasms, Hereditary Nonpolyposis , Dermatomyositis , Polymyositis | | Pms2 | Brain Neoplasms , Breast Neoplasms , Cafe-au-Lait Spots , Colonic Neoplasms , Colorectal Neoplasms , Colorectal Neoplasms, Hereditary Nonpolyposis , Glioblastoma , Neuroectodermal Tumors, Primitive , Ovarian Neoplasms , Prostatic Neoplasms , Supratentorial Neoplasms , Turcot syndrome , Urinary Bladder Neoplasms | |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Muir-Torre Syndrome | Msh2 , Mlh1 | | Metabolism, Inborn Errors | Lig1 | | Brain Neoplasms | Pms2 | | Carcinoma, Renal Cell | Pcna , Msh2 , Mlh1 | | Seizures | Msh2 | | Cafe-au-Lait Spots | Pms2 | | Immunologic Deficiency Syndromes | Lig1 | | Colorectal Neoplasms, Hereditary Nonpolyposis | Msh2 , Mlh1 , Pms2 , Mlh3 , Pms1 | | Ovarian Neoplasms | Msh2 , Pms2 | | Breast Neoplasms | Pcna , Msh2 , Mlh1 , Pms2 | | Wilms Tumor | Pcna | | Uterine Cervical Neoplasms | Msh2 , Mlh1 | | Urinary Bladder Neoplasms | Msh2 , Mlh1 , Pms2 | | Turcot syndrome | Msh2 , Mlh1 , Pms2 | | Colorectal Neoplasms | Msh2 , Mlh1 , Pms2 , Mlh3 , Pms1 , Msh3 | | Prostatic Neoplasms | Msh2 , Pms2 | | Lynch syndrome I (site-specific colonic cancer) | Msh2 | | Neoplasms, Germ Cell and Embryonal | Pcna , Msh2 , Mlh1 | | Dermatomyositis | Pms1 | | Phyllodes Tumor | Pcna | | Digestive System Neoplasms | Msh3 | | Brain Ischemia | Pcna | | Hydatidiform Mole, Invasive | Msh2 | | Hydatidiform Mole | Msh2 , Mlh1 | | Colonic Neoplasms | Pms2 | | Polymyositis | Pms1 | | Urogenital Neoplasms | Msh2 | | Glioblastoma | Pms2 | | Neoplasms, Multiple Primary | Mlh1 | | Supratentorial Neoplasms | Pms2 | | Leiomyoma | Pcna | | Neoplasm Metastasis | Pcna , Msh2 | | Neuroectodermal Tumors, Primitive | Pms2 | | Testicular Neoplasms | Pcna | | Vulvar Neoplasms | Msh2 , Mlh1 | | Endometrial Neoplasms | Msh2 , Mlh1 , Mlh3 , Msh3 | | Seminoma | Pcna | | Carcinoma, Ductal, Breast | Pcna | | Cervical Intraepithelial Neoplasia | Msh2 , Mlh1 | | Carcinoma, Pancreatic Ductal | Pms1 | | Lynch Syndrome II | Mlh1 | |
|